Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

Malcles, Ariane; Dot, Corinne; Voirin, Nicolas; Vie, Anne-Laure; Agard, Émilie; Bellocq, David; Denis, Philippe; Kodjikian, Laurent

doi:10.1097/IAE.0000000000001369

Scientific article

English

Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

ContributorsMalcles, Ariane

; Dot, Corinne; Voirin, Nicolas; Vie, Anne-Laure; Agard, Émilie; Bellocq, David; Denis, Philippe; Kodjikian, Laurent

Published inRetina, vol. 37, no. 7, p. 1352-1359

Publication date2017

Abstract

To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Research groups

Ophtalmologie expérimentale (925)

Citation (ISO format)

MALCLES, Ariane et al. Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension. In: Retina, 2017, vol. 37, n° 7, p. 1352–1359. doi: 10.1097/IAE.0000000000001369

Article (Published version)

Identifiers

PID : unige:92783
DOI : 10.1097/IAE.0000000000001369
PMID : 27768641

Journal ISSN1539-2864

589views

773downloads

Creation29/11/2016 14:39:00

First validation29/11/2016 14:39:00

Update time15/03/2023 01:29:27

Status update15/03/2023 01:29:27

Last indexation31/10/2024 06:30:15

Archive ouverte UNIGE

Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).

Technical informations